Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.
cardiac shock
2 other identifiers
observational
1,650
1 country
1
Brief Summary
Cardiogenic shock (CC) is one of the major challenges of current cardiology. Despite the difficulty of establishing a strict and consensual definition, it is accepted that the CC clinically corresponds to persistent hypotension (systolic blood pressure 90 mmHg for at least 30 minutes or need for vasopressor support) associated with signs of visceral hypoperfusion (confusion, mottling, oliguria, hyperlactatemia), and hemodynamic with a lowered heart index ( 1.8 L/min/m2) despite appropriate or high filling pressures. This definition of the European Society of Cardiology (ESC) masks however the great variability of hemodynamic tables grouped under the term of CC and severity levels, also variable.However, it was suggested that the etiology of CC influenced both its hemodynamic profile and therefore its therapeutic management but also its prognosis in the medium and long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2020
CompletedFirst Submitted
Initial submission to the registry
July 8, 2020
CompletedFirst Posted
Study publicly available on registry
July 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2023
CompletedJuly 13, 2020
July 1, 2020
3 years
July 8, 2020
July 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of Cardiac Shock
12 months
Secondary Outcomes (2)
mortality
one month
mortality
one year
Eligibility Criteria
Patients in Cardiac Shock and patients admitted for acute heart failure (ICA)
You may qualify if:
- Patients in Cardiac Shock :
- mmHg hypotension or requiring inotropic or vasopressor support,
- owered cardiac output ( 1.8 L/min/m2) to trans-thoracic cardiac ultrasound with high or normal filling pressures
- peripheral hypoperfusion. patients admitted for acute heart failure (ICA) (Acute pulmonary edema chart or left congestive heart failure without CC sign and with ultrasound FEVG at entry 40%.)
You may not qualify if:
- Pregnant or nursing women
- Age 18 years
- Person of full age under guardianship
- Staying in a health or social facility
- Person not covered by a social security scheme
- Person deprived of liberty
- Shocks from other etiologies
- Patient with initial cardiac arrest
- Patient with cardiogenic shock due to right ventricular dysfunction
- Patient with pulmonary embolism
- Patient with tamponade
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hopitaux de Marseille
Marseille, PACA, 13354, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Garrido-pradalie Emilie
ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2020
First Posted
July 13, 2020
Study Start
April 4, 2020
Primary Completion
April 4, 2023
Study Completion
October 4, 2023
Last Updated
July 13, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share